Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.

Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.

Contact SupportLog In

Posted in: Basal Insulin, GLP-1RA, Other, SGLT2i May 03 | 2024Novo London, Tandem, and Lexicon Q1 ’24 EarningsPurchase Blast
Posted in: Dual/triple agonist, GLP-1RA, Other May 02 | 2024Amgen, Regeneron, and Alnylam Q1 ’24 EarningsPurchase Blast
Posted in: Basal Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Other May 02 | 2024Novo to Face Two FDA Adcoms in 2024; Novo Q1 ‘24 EarningsPurchase Blast
senseonics cover image
Posted in: Glucose Monitoring, Insulin Delivery, Other Apr 30 | 2024Eversense CGM Receives iCGM DesignationPurchase Blast
novo cover image
Posted in: Basal Insulin Apr 26 | 2024Icodec FDA Adcom Scheduled for May 2024Purchase Blast
1 2 3 89